Implementation of the cross-border healthcare directive in Poland: How not to encourage patients to seek care abroad?

- This article describes the background Dand content of the law transposing directive 2011/24/EU in Poland.
- The article focuse on the barriers to accessing healthcare abroad within the directive imposed by the Polish government.
- The article analyses the volume of patient mobility under the directive and demonstrates that the government's fear of the 'exodus' of Polish patients abroad have been largely unwarranted.

In October 2014, after over 12 months of delay, Poland finally implemented directive 2011/24/EU on the application of patients' rights in cross-border healthcare. The implementing legislation in the area of cost reimbursement and prior authorization is very restrictive. The goal is to either defer the public payer's expenses into the future or to discourage patients from seeking care abroad or from seeking care altogether. The Polish government and the Ministry of Health, the key stakeholders in the implementation process, seemed to overlook the potential monetary benefits that the implementation of the directive could bring, for example, by promoting Poland as a destination for health tourism. Other stakeholders, such as patients and healthcare providers, had no real influence on the policy process. So far, the number of applications for planned treatment abroad has been very low and the majority of them were actually turned down as they did not meet the formal requirements. This number is likely to remain low in the future as accessing such care is cumbersome and not affordable for many patients. Overall, while the directive does not aim to encourage patients to seek cross-border healthcare, the current national regulations in Poland do not seem to facilitate access to cross-border healthcare, which is the main goal of the directive.